Drugs / RVEc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02385825 | Apr 2016 → Jun 2017 | ricin poisoning | U.S. Army Medical Research and Development Command | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RVEc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02385825 ↗ |
| Modality | Vaccine | “Recombinant ricin toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine” NCT02385825 ↗ |
| Route | Intramuscular | “Administered Intramuscularly” NCT02385825 ↗ |